[1]Merlini G,Bellotti V. Molecular mechanisms of amyloidosis[J].N Engl J Med,2003,349(6):583-596.
[2]Rajkumar SV,Gertz MA. Advances in the treatment of amyloidosis[J].N Engl J Med,2007,356(23):2413-2415.
[3]Comenzo RL,Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis[J].Blood,2002,99(12):4276-4282.
[4]Gertz MA,Comenzo R,Falk RH,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis(AL):a consensus opinion from the 10th international symposium on amyloid and amyloidosis,Tours,France,18-22 April 2004[J].Am J Hematol,2005,79(4):319-328.
[5]Cruz DN,Bagshaw SM,Ronco C,et al.Acute kidney injury:classification and staging[J].Contrib Nephrol,2010,164:24-32.
[6]陈炜生,陈 龙,杨胜生,等.持续肾脏替代疗法治疗心脏移植术后急性肾功能衰竭[J].东南国防医药,2005,7(1):35-36.
[7]王 佳,余 毅,孙淑清,等.局部枸橼酸体外抗凝在高危出血风险患者持续肾脏替代治疗中的应用[J].中国血液净化,2015,7(14):404-407.
[8]张海霞,王丽文.对肝移植术后急性肾功能衰竭患者应用无肝素连续性肾脏替代治疗的护理[J].透析与人工器官,2014,25(3):37-39.
[9]杨洪娟,刘秋香.危重患者下肢深静脉血栓的预防和护理[J].东南国防医药,2011,13(4):339-341.
[10]胡小萍,诸纪芬,罗会华,等.预充式导管冲洗器在静脉留置针封管中的效果观察[J].全科护理,2013,11(10):2829-2830.
[11]周 虹,姚 丽,赵 闽.淀粉样变性患者自体造血干细胞移植术后血小板输注无效的护理[J].护理学杂志,2012,27(23):36-37.